Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07696403 · ClinicalTrials.gov registry record · NA
Cardiometabolic Effects of the Recommended Daily Pecan Intake Dose
A NA study, sponsored by University of Georgia.
- Not yet
- Registry status
- NA
- Development phase
- 90
- Enrollment target
NCT07696403 is a NA study that has not yet begun recruiting, run by University of Georgia. The registered enrollment target is 90 participants.
The verdict
NCT07696403, a NA study, has not yet begun recruiting, sponsored by University of Georgia.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
Study Summary
Cardiovascular disease risk factors, including higher BMIs and poor cholesterol profiles, are on the rise and contribute to the United States' growing disease burden. The bioactive compounds contained in tree nuts have been shown to beneficially affect cardiometabolic health outcomes. Pecans contain more total phenols, sterols, and flavonoids than any other tree nut. They also are a rich source of polyunsaturated fatty acids (PUFAs), fiber, vitamin A, vitamin E, folic acid, calcium, magnesium, phosphorus, potassium, and zinc. These bioactive components in pecans are likely the reason for the previously documented improvements in cardiometabolic health. This study aims to examine the impact of a low dose of pecans on changes in fasting and postprandial lipid metabolism/blood lipids and markers of chronic disease risk. The specific aims of this study are to: * Examine the effect of pecan consumption at a dose of 6% of total energy needs for 12 weeks on fasting and postprandial blood lipids. * Examine the effect of pecan consumption at a dose of 6% of total energy needs for 12 weeks on other markers of chronic disease risk. Participants will be asked to: * Consume pecans daily for 12 weeks or maintain their current habitual diet. * Attend two short visits at 4 and 8 weeks for fasting blood draws, body measurements, and to collect their next 4 weeks' supply of study materials. * Attend two longer (5 h) testing visits, which include eating a standard breakfast meal and having their blood drawn periodically before and after breakfast. Researchers will compare the Pecan and Control groups to examine the physiologic effects of incorporating a low dose of pecans into one's diet.
Interventions
- OTHER Control
- OTHER Pecan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2026-08 |
| Est. Completion | 2029-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07696403
The ClinicalTrials.gov registry entry for NCT07696403 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Georgia, which has 59 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Control is the first listed.
NCT07696403 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07696403 about?
NCT07696403 is a clinical study titled "Cardiometabolic Effects of the Recommended Daily Pecan Intake Dose". Cardiovascular disease risk factors, including higher BMIs and poor cholesterol profiles, are on the rise and contribute to the United States' growing disease burden. The bioactive compounds contained in tree nuts have been shown to beneficially affect cardiometabolic health outcomes. Pecans contain...
What is the current status of trial NCT07696403?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 90 participants. The study started on 2026-08. Estimated completion is 2029-07.
What interventions are being tested in trial NCT07696403?
The interventions under investigation include: Control (OTHER), Pecan (OTHER).
Who is sponsoring clinical trial NCT07696403?
This trial is sponsored by University of Georgia, which has 59 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.